Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prism adaptation rehabilitation with methylphenidate for post-stroke hemispatial neglect
2008-000325-20Phase 3Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylphenidate in hemispatial neglect (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Functional Independence Measure score at 1 week after treatment discontinuation. Started Apr 2008; status: active.
02
Drugs
methylphenidate
03
Conditions
hemispatial neglect
Beyond the preview
Go deeper on 2008-000325-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000325-20.